Home » Topics » Regulatory

Regulatory
RSS

Flavopiridol, a known antitumor agent, now reported effective in models of vascular injury

Sep. 7, 2000

FDA approves ciprofloxacin for treatment of postexposure inhalational anthrax

Sep. 7, 2000

Use of AII receptor antagonists in prevention, treatment of AMI

Sep. 7, 2000

New use for topiramate: bulimia nervosa Rx

Sep. 6, 2000

Anticonvulsants for cluster headache

Sep. 6, 2000

Topiramate has beneficial effects in transformed migraine

Sep. 6, 2000

Tripedia receives FDA approval for use in the entire DTP immunization series

Sep. 6, 2000

Taxotere combination therapy approved in E.U. for treatment of advanced breast cancer

Sep. 5, 2000

Zometa approved in Canada for treatment of tumor-induced hypercalcemia

Aug. 31, 2000

Tablet form of Rapamune receives FDA approval

Aug. 30, 2000

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...